Triastek
PrivateLast Round
VC Round
Sep 28, 2023
Est. Valuation
$541M
Total Funding Raised
$80.4M
Company Overview
Triastek is a pharmaceutical technology company that specializes in innovative 3D printing solutions for the development and production of drug delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triastek Comparables
Compare Triastek with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laxxon Medical | 80% | |
| Aprecia Pharmaceuticals | 76% | |
| Biora Therapeutics | 68% |
Triastek Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 28, 2023 | ||||
| Series B Extension | Nov 23, 2021 | ||||
| Series B | Jun 24, 2021 | ||||
| Series A | Dec 15, 2020 | ||||
| Series A | Jun 1, 2018 |
Triastek Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B Extension, Series B |
| Goldmine Multi-family Office | VC Round |
| Tasly Holding Group | Series B |
| Dalton Venture | Series B, Series A |
| Triwise Capital | Series B Extension |
| Morningside Ventures | Series B |
| CITIC Private Equity Funds Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 218% MoM, from 343 to 1.1K.
- Sep 28, 2023
$20.4M raised from Goldmine Multi-family Office and others.
Triastek Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Triastek's valuation, stock price, and market status.
Is Triastek a public or private company?
Triastek is a private company.
What is the current stock price of Triastek?
Triastek is a private company, so its shares have no public market price. Caplight tracks Triastek's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Triastek worth (valuation)?
Triastek's valuation is estimated at $541.0M based on funding round data.
Can I buy Triastek stock?
Triastek shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Triastek's last funding round?
Triastek's most recent funding round was VC Round on September 28, 2023.
Who are the main investors in Triastek?
Key investors in Triastek include Matrix, Dalton Venture, Triwise Capital, CITIC Private Equity Funds Management, 5Y Capital.
Will Triastek IPO soon?
No public IPO plans have been announced for Triastek.
How can I track Triastek secondary market activity?
Caplight tracks bids, offers, and trades in Triastek's shares on secondary markets.